These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22557743)

  • 1. Toxicity of topical lidocaine applied to the breasts to reduce discomfort during screening mammography.
    Lambertz CK; Johnson CJ; Montgomery PG; Maxwell JR; Fry SJ
    J Anaesthesiol Clin Pharmacol; 2012 Apr; 28(2):200-4. PubMed ID: 22557743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 4% topical lidocaine applied to the face on the serum levels of lidocaine and its metabolite, monoethylglycinexylidide.
    Oni G; Brown S; Burrus C; Grant L; Watkins J; Kenkel M; Barton F; Kenkel J
    Aesthet Surg J; 2010; 30(6):853-8. PubMed ID: 21131461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of five commonly-available, lidocaine-containing topical anesthetics and their effect on serum levels of lidocaine and its metabolite monoethylglycinexylidide (MEGX).
    Oni G; Brown S; Kenkel J
    Aesthet Surg J; 2012 May; 32(4):495-503. PubMed ID: 22452841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of monoethylglycinexylidide during and after breast augmentation.
    Rygnestad T; Samdal F
    Plast Reconstr Surg; 2000 Sep; 106(3):728-31. PubMed ID: 10987485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premedication to reduce discomfort during screening mammography.
    Lambertz CK; Johnson CJ; Montgomery PG; Maxwell JR
    Radiology; 2008 Sep; 248(3):765-72. PubMed ID: 18647845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxic shock alters the pharmacokinetics of lidocaine and monoethylglycinexylidide.
    McKindley DS; Boulet J; Sachdeva K; Wang P; Chichester C
    Shock; 2002 Mar; 17(3):199-204. PubMed ID: 11900338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver function tests and lidocaine metabolism (MEGX test) during i.v. CMF therapy in breast cancer.
    Rizzi V; Cioschi B; Cartei G; Bertolissi A; Tabaro G; Marsilio P
    Anticancer Drugs; 1996 Nov; 7(8):846-50. PubMed ID: 8991188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of lidocaine following the application of 5% lidocaine patches to cats.
    Ko JC; Maxwell LK; Abbo LA; Weil AB
    J Vet Pharmacol Ther; 2008 Aug; 31(4):359-67. PubMed ID: 18638297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentrations of lidocaine and its metabolites after prolonged infusion in healthy horses.
    Dickey EJ; McKenzie HC; Brown KA; de Solis CN
    Equine Vet J; 2008 Jun; 40(4):348-52. PubMed ID: 18267881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proof of systemic safety of a lidocaine ointment in the treatment of patients with anorectal pain.
    Zimmermann J; Schlegelmilch R; Mazur D; Seiler D; Vens-Cappell B
    Arzneimittelforschung; 2007; 57(1):12-9. PubMed ID: 17341004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of monoethylglycinexylidide in body fluids of deceased patients after use of lidocaine for endotracheal intubation.
    Moriya F; Hashimoto Y
    Leg Med (Tokyo); 2000 Mar; 2(1):31-5. PubMed ID: 12935463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of lidocaine and its principal metabolites during continuous epidural infusion of lidocaine with or without epinephrine.
    Kihara S; Miyabe M; Kakiuchi Y; Takahashi S; Fukuda T; Kohda Y; Toyooka H
    Reg Anesth Pain Med; 1999; 24(6):529-33. PubMed ID: 10588557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of an extended monoethylglycinexylidide formation test and other dynamic liver function tests in liver transplant donors.
    Zotz RB; von Schönfeld J; Erhard J; Breuer N; Lange R; Beste M; Goebell H; Eigler FW
    Transplantation; 1997 Feb; 63(4):538-41. PubMed ID: 9047147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring lidocaine metabolite--monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis.
    Huang YS; Lee SD; Deng JF; Wu JC; Lu RH; Lin YF; Wang YJ; Lo KJ
    J Hepatol; 1993 Aug; 19(1):140-7. PubMed ID: 8301034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lidocaine and MEGX concentrations after pharyngeal anesthesia for gastroscopy.
    Soda K; Shimanuki K; Yoshida Y; Seo N; Yamanaka T; Sakurabayashi I; Miyata M
    Endoscopy; 1994 May; 26(4):347-51. PubMed ID: 8076566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of occluded 4% liposomal lidocaine cream.
    Nestor MS
    J Drugs Dermatol; 2006; 5(7):618-20. PubMed ID: 16865866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epinephrine does not reduce the plasma concentration of lidocaine during continuous epidural infusion in children.
    Miyabe M; Kakiuchi Y; Inomata S; Ohsaka Y; Kohda Y; Toyooka H
    Can J Anaesth; 2002; 49(7):706-10. PubMed ID: 12193490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various ages.
    Drayer DE; Lorenzo B; Werns S; Reidenberg MM
    Clin Pharmacol Ther; 1983 Jul; 34(1):14-22. PubMed ID: 6861434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatographic determination of free lidocaine and its active metabolites in plasma from patients under epidural anesthesia.
    Kakiuchi Y; Fukuda T; Miyabe M; Homma M; Toyooka H; Kohda Y
    Int J Clin Pharmacol Ther; 2002 Nov; 40(11):493-8. PubMed ID: 12698986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosis.
    Testa R; Campo N; Caglieris S; Risso D; Alvarez S; Arzani L; Giannini E; Lantieri PB; Celle G
    Hepatogastroenterology; 1998; 45(19):154-9. PubMed ID: 9496506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.